,reactionmeddraversionpt,reactionmeddrapt,safetyreportid,reactionoutcome
0,21.1,Nasopharyngitis,15859678,
1,21.1,Infection,15859678,
0,21.1,Localised infection,15859684,
1,21.1,Eye irritation,15859684,
2,21.1,Skin infection,15859684,
3,21.1,Erythema,15859684,
4,21.1,Palmar-plantar erythrodysaesthesia syndrome,15859684,
5,21.1,Dry eye,15859684,
0,21.1,Diarrhoea,15859691,
1,21.1,Dehydration,15859691,
0,21.1,Drug ineffective,15859697,6
0,21.1,Meningioma,15859700,1
0,21.1,Hot flush,15859701,
1,21.1,Oedema peripheral,15859701,
0,21.1,Pneumonia,15859704,2
1,21.1,Atrial fibrillation,15859704,2
0,21.1,Alopecia,15859754,2
0,22.0,Central nervous system lesion,15859831,6
1,22.0,Vertigo,15859831,1
2,22.0,Visual field defect,15859831,1
3,22.0,Headache,15859831,1
4,22.0,Neutropenia,15859831,1
5,22.0,Lymphocyte count decreased,15859831,6
6,22.0,Transient ischaemic attack,15859831,6
7,22.0,Diplopia,15859831,1
8,22.0,Arteriosclerosis,15859831,6
9,22.0,Cerebral microangiopathy,15859831,6
0,22.0,Leukaemic lymphoma,15859834,5
1,22.0,Second primary malignancy,15859834,5
2,22.0,Diffuse large B-cell lymphoma,15859834,5
0,21.1,Incoherent,15859869,6
1,21.1,Decreased appetite,15859869,6
2,21.1,Gait disturbance,15859869,6
3,21.1,Blood glucose abnormal,15859869,6
0,21.1,Haemoglobin decreased,15859928,2
0,21.1,Electrocardiogram QT prolonged,15859931,3
1,21.1,Dyspnoea,15859931,3
2,21.1,Cardiac disorder,15859931,3
0,21.1,Pruritus,15859933,1
1,21.1,Neuropathy peripheral,15859933,2
2,21.1,Rash,15859933,2
3,21.1,Nail disorder,15859933,1
4,21.1,Epistaxis,15859933,1
5,21.1,Hypersensitivity,15859933,1
0,22.0,Neutropenia,15859977,1
1,22.0,Agranulocytosis,15859977,1
0,22.0,Influenza,15859990,6
1,22.0,Platelet count decreased,15859990,6
2,22.0,Off label use,15859990,6
3,22.0,Drug level fluctuating,15859990,3
4,22.0,Insomnia,15859990,6
5,22.0,Oropharyngeal pain,15859990,6
6,22.0,Malaise,15859990,3
0,22.0,Pneumatosis intestinalis,15860009,2
1,22.0,Ileus,15860009,2
0,22.1,Influenza like illness,15860058,6
1,22.1,Drug interaction,15860058,1
2,22.1,Off label use,15860058,6
3,22.1,Blood loss anaemia,15860058,1
4,22.1,Product use issue,15860058,6
5,22.1,Fatigue,15860058,2
0,21.1,Pneumonia,15860101,6
0,21.1,Pyrexia,15860102,1
1,21.1,Urinary retention,15860102,1
2,21.1,Mental status changes,15860102,3
0,21.1,Non-small cell lung cancer,15860147,6
1,21.1,Cell death,15860147,6
2,21.1,Blood pressure increased,15860147,1
0,21.1,Electrocardiogram abnormal,15860155,6
1,21.1,Neoplasm progression,15860155,6
2,21.1,Creatinine renal clearance abnormal,15860155,1
3,21.1,Dyspnoea,15860155,6
4,21.1,Platelet disorder,15860155,6
5,21.1,Neutrophil count increased,15860155,6
6,21.1,Blood potassium increased,15860155,6
7,21.1,Weight decreased,15860155,6
0,21.1,Neoplasm progression,15860250,6
0,22.0,Hair colour changes,15860302,3
1,22.0,Hair texture abnormal,15860302,3
2,22.0,Hair disorder,15860302,3
3,22.0,Alopecia,15860302,3
0,21.1,Death,15860330,5
0,21.1,Pneumonitis,15860343,1
0,21.1,Encephalopathy,15860378,1
1,21.1,Haemoptysis,15860378,1
0,22.1,Pruritus,15860379,6
1,22.1,Death,15860379,5
2,22.1,Intentional product use issue,15860379,6
3,22.1,Pleural effusion,15860379,6
0,21.1,Androgen receptor gene overexpression,15860427,6
1,21.1,Prostate cancer,15860427,6
2,21.1,PTEN gene mutation,15860427,6
0,21.1,Urinary retention,15860431,6
1,21.1,Small intestinal obstruction,15860431,5
2,21.1,Dyspnoea,15860431,6
0,21.1,Death,15860449,5
1,21.1,Off label use,15860449,6
0,21.1,Death,15860450,5
0,21.1,Death,15860451,5
0,22.0,Impaired healing,15860452,6
1,22.0,Oedema peripheral,15860452,6
2,22.0,Fatigue,15860452,6
3,22.0,Necrosis,15860452,6
4,22.0,Wound infection,15860452,2
5,22.0,Pleural effusion,15860452,6
6,22.0,Ascites,15860452,6
7,22.0,Weight decreased,15860452,6
8,22.0,Blood pressure increased,15860452,3
0,22.1,Alanine aminotransferase increased,15860469,1
0,21.1,Paravenous drug administration,15860537,6
1,21.1,Erythema,15860537,2
0,21.1,Atrial fibrillation,15860543,1
0,21.1,Fall,15860545,6
1,21.1,Fracture,15860545,6
0,21.1,Pancreatitis necrotising,15860552,2
0,21.1,Condition aggravated,15860607,6
1,21.1,Pneumonia,15860607,6
0,21.1,Prescribed underdose,15860637,6
1,21.1,Ischaemic stroke,15860637,2
0,21.1,Acute kidney injury,15860699,5
1,21.1,Cardiac failure congestive,15860699,5
2,21.1,Prostate cancer,15860699,5
0,21.1,Palmar-plantar erythrodysaesthesia syndrome,15860705,2
1,21.1,Mucosal inflammation,15860705,1
2,21.1,Toxicity to various agents,15860705,6
3,21.1,Pneumothorax,15860705,1
4,21.1,Pleural effusion,15860705,1
5,21.1,Diarrhoea,15860705,1
6,21.1,Transaminases increased,15860705,1
7,21.1,Nausea,15860705,1
8,21.1,Asthenia,15860705,1
0,21.1,Hyperthyroidism,15860717,3
1,21.1,Myocarditis,15860717,3
2,21.1,Autoimmune thyroiditis,15860717,3
3,21.1,Diabetic ketoacidosis,15860717,3
0,21.1,Off label use,15860750,6
1,21.1,Malaise,15860750,6
2,21.1,Diarrhoea,15860750,6
3,21.1,Polyneuropathy,15860750,6
4,21.1,Haemoglobin decreased,15860750,1
5,21.1,Malaise,15860750,6
6,21.1,Neuropathy peripheral,15860750,6
7,21.1,White blood cell count decreased,15860750,6
8,21.1,Nausea,15860750,6
9,21.1,Purpura,15860750,1
10,21.1,Neuralgia,15860750,6
11,21.1,Drug effect incomplete,15860750,6
12,21.1,Feeling abnormal,15860750,6
13,21.1,Metastases to lymph nodes,15860750,6
14,21.1,Fatigue,15860750,6
15,21.1,Thrombocytopenic purpura,15860750,6
16,21.1,Product use in unapproved indication,15860750,6
17,21.1,Vomiting,15860750,6
18,21.1,Neutropenia,15860750,1
19,21.1,Thrombocytopenia,15860750,1
20,21.1,Platelet count decreased,15860750,6
21,21.1,Abdominal pain,15860750,6
22,21.1,Disease progression,15860750,6
23,21.1,Asthenia,15860750,6
24,21.1,Fatigue,15860750,6
25,21.1,Asthenia,15860750,6
0,21.1,Abdominal pain,15860792,6
1,21.1,Diarrhoea,15860792,6
2,21.1,Palmar-plantar erythrodysaesthesia syndrome,15860792,6
3,21.1,Peripheral sensory neuropathy,15860792,6
4,21.1,Nausea,15860792,6
5,21.1,Aspartate aminotransferase increased,15860792,6
6,21.1,Amylase increased,15860792,6
7,21.1,Infection,15860792,6
8,21.1,Alanine aminotransferase increased,15860792,6
9,21.1,Fatigue,15860792,6
10,21.1,Neutropenia,15860792,6
11,21.1,Vomiting,15860792,6
0,21.1,Back disorder,15860840,6
1,21.1,Hot flush,15860840,3
2,21.1,Buttock injury,15860840,6
3,21.1,Fractured sacrum,15860840,6
4,21.1,Weight increased,15860840,6
5,21.1,Hypoaesthesia,15860840,3
6,21.1,Hypoaesthesia,15860840,3
7,21.1,Pain,15860840,6
8,21.1,Lumbar vertebral fracture,15860840,1
9,21.1,Osteoporosis,15860840,6
10,21.1,Condition aggravated,15860840,3
11,21.1,Walking aid user,15860840,6
0,21.1,Product substitution issue,15860862,1
1,21.1,Breast tenderness,15860862,1
2,21.1,Discomfort,15860862,1
3,21.1,Pain,15860862,1
0,22.0,Transaminases increased,15860864,6
1,22.0,Musculoskeletal pain,15860864,6
2,22.0,Mucosal inflammation,15860864,6
3,22.0,Fatigue,15860864,6
0,22.0,Mucosal inflammation,15860974,6
1,22.0,Constipation,15860974,2
2,22.0,Nausea,15860974,3
3,22.0,Maternal exposure during pregnancy,15860974,3
4,22.0,Rhinitis,15860974,6
5,22.0,Fatigue,15860974,2
0,21.1,Wrong technique in product usage process,15860997,6
0,21.1,Rectal cancer,15860999,3
1,21.1,Rectal haemorrhage,15860999,6
0,21.1,Product use in unapproved indication,15861053,6
1,21.1,Adverse event,15861053,6
2,21.1,Adverse event,15861053,6
3,21.1,Adverse event,15861053,1
0,21.1,Stomatitis,15861137,6
0,21.1,Peritonitis,15861149,2
1,21.1,Large intestine perforation,15861149,2
0,21.1,Hypersomnia,15861206,3
1,21.1,Nasopharyngitis,15861206,3
2,21.1,Oropharyngeal pain,15861206,3
3,21.1,Lung disorder,15861206,3
0,21.1,Death,15861240,5
0,21.1,Malignant melanoma,15861260,6
1,21.1,Renal neoplasm,15861260,6
0,21.1,Renal failure,15861280,5
1,21.1,Prostate cancer,15861280,5
0,21.1,Meningioma,15861291,1
1,21.1,Incorrect route of product administration,15861291,6
0,22.0,Spinal cord disorder,15861306,2
1,22.0,Pulmonary embolism,15861306,2
2,22.0,Gait inability,15861306,2
3,22.0,Sensory loss,15861306,2
4,22.0,Hydronephrosis,15861306,2
5,22.0,Metastases to liver,15861306,2
6,22.0,Spinal cord abscess,15861306,2
7,22.0,Prostate cancer,15861306,5
8,22.0,Escherichia bacteraemia,15861306,2
0,22.0,Rectal ulcer haemorrhage,15861311,2
1,22.0,Asthenia,15861311,2
2,22.0,Prostatic specific antigen increased,15861311,2
3,22.0,Rectal abscess,15861311,2
4,22.0,Anaemia,15861311,2
5,22.0,Iron deficiency,15861311,2
6,22.0,Fatigue,15861311,2
0,21.1,Prostate cancer,15861321,5
0,21.1,Death,15861329,5
0,21.1,Pre-existing disease,15861341,5
0,21.1,Hot flush,15861348,1
1,21.1,Urinary tract infection,15861348,1
2,21.1,Arthralgia,15861348,1
3,21.1,Inappropriate schedule of product administration,15861348,6
0,22.0,Lung disorder,15861381,5
0,21.1,Diarrhoea,15861390,1
1,21.1,Discomfort,15861390,1
0,21.1,Decreased appetite,15861405,6
1,21.1,Jaundice,15861405,5
2,21.1,Deficiency of bile secretion,15861405,6
3,21.1,Choluria,15861405,6
4,21.1,Abdominal pain,15861405,6
5,21.1,Nausea,15861405,5
6,21.1,Mucosal inflammation,15861405,5
7,21.1,Confusional state,15861405,5
0,21.1,White blood cell count decreased,15861442,2
1,21.1,Hepatic function abnormal,15861442,2
2,21.1,Neutrophil count decreased,15861442,2
0,21.1,Abscess,15861557,6
1,21.1,Deep vein thrombosis,15861557,6
2,21.1,Neutrophil count decreased,15861557,6
3,21.1,Drug hypersensitivity,15861557,6
0,21.1,Ischaemic stroke,15861559,4
0,21.1,Skin ulcer,15861579,
0,21.1,Neutropenia,15861593,1
1,21.1,Anaemia,15861593,3
2,21.1,Platelet count decreased,15861593,1
3,21.1,Drug interaction,15861593,6
0,21.1,Vomiting,15861597,3
1,21.1,Metrorrhagia,15861597,3
2,21.1,Anaemia,15861597,3
3,21.1,Subileus,15861597,3
4,21.1,Diarrhoea,15861597,3
5,21.1,General physical health deterioration,15861597,3
6,21.1,Pyrexia,15861597,3
0,21.1,Ejection fraction decreased,15861612,1
0,21.1,Ureteral stent insertion,15861671,6
0,21.1,Alopecia,15861761,3
1,21.1,Madarosis,15861761,3
2,21.1,Hair disorder,15861761,3
3,21.1,Hair texture abnormal,15861761,3
4,21.1,Hair colour changes,15861761,3
0,22.0,Fatigue,15861788,6
1,22.0,Diarrhoea,15861788,6
2,22.0,Nausea,15861788,6
3,22.0,Neoplasm progression,15861788,6
0,22.0,Product use issue,15861791,6
1,22.0,Application site pain,15861791,1
2,22.0,Burning sensation,15861791,1
3,22.0,Periorbital oedema,15861791,1
0,21.1,Hypertension,15861838,6
1,21.1,Fatigue,15861838,6
0,21.1,Hair texture abnormal,15861874,3
1,21.1,Alopecia,15861874,3
2,21.1,Hair colour changes,15861874,3
3,21.1,Hair disorder,15861874,3
0,21.1,Product complaint,15861899,6
1,21.1,Application site erosion,15861899,6
2,21.1,Application site irritation,15861899,6
3,21.1,Product use in unapproved indication,15861899,6
4,21.1,Application site pain,15861899,6
5,21.1,Contraindicated product administered,15861899,6
0,21.1,Upper respiratory tract infection,15862064,4
1,21.1,Lung infection,15862064,5
2,21.1,Pyrexia,15862064,1
0,21.1,Microcytic anaemia,15862074,2
1,21.1,Diarrhoea,15862074,2
2,21.1,Rash,15862074,6
3,21.1,Vomiting,15862074,6
0,21.1,Death,15862086,
0,21.1,Rhinorrhoea,15862113,6
1,21.1,Lacrimal disorder,15862113,6
2,21.1,Apnoea,15862113,6
3,21.1,Swelling face,15862113,6
4,21.1,Swelling,15862113,6
0,21.1,Sudden cardiac death,15862165,5
1,21.1,Hypertension,15862165,6
2,21.1,Proteinuria,15862165,6
0,22.0,Gastrointestinal perforation,15862172,5
1,22.0,Diarrhoea,15862172,2
0,21.1,Urticaria,15862244,2
1,21.1,Pruritus generalised,15862244,3
0,21.1,Neuroendocrine carcinoma,15862250,5
1,21.1,Hepatic failure,15862250,5
2,21.1,Recurrent cancer,15862250,5
3,21.1,Metastases to liver,15862250,5
0,21.1,Weight increased,15862257,
0,21.1,Osteonecrosis of jaw,15862320,6
0,21.1,Death,15862362,5
0,22.0,Madarosis,15862381,3
1,22.0,Hair disorder,15862381,3
2,22.0,Anxiety,15862381,6
3,22.0,Speech disorder,15862381,6
4,22.0,Hair colour changes,15862381,3
5,22.0,Alopecia,15862381,3
6,22.0,Amnesia,15862381,6
7,22.0,Hair texture abnormal,15862381,3
0,21.1,Hair disorder,15862386,3
1,21.1,Madarosis,15862386,3
2,21.1,Hair colour changes,15862386,3
3,21.1,Alopecia,15862386,3
4,21.1,Hair texture abnormal,15862386,3
0,21.1,Neutrophil count decreased,15862389,1
1,21.1,Pneumonia,15862389,3
2,21.1,Influenza,15862389,1
0,21.1,Acute myeloid leukaemia,15862519,
0,21.1,Enteritis,15862532,1
1,21.1,Small intestinal obstruction,15862532,1
0,21.1,Peripheral swelling,15862536,3
1,21.1,Joint swelling,15862536,6
2,21.1,Lymphadenopathy,15862536,6
0,21.1,Peripheral ischaemia,15862582,2
1,21.1,Arterial thrombosis,15862582,2
0,21.1,Death,15862615,
0,21.1,Bone marrow failure,15862669,6
0,21.1,Malaise,15862679,3
1,21.1,Loss of consciousness,15862679,3
2,21.1,Nuclear magnetic resonance imaging abnormal,15862679,3
0,21.1,Prostate cancer stage IV,15862750,
0,21.1,Hypotension,15862776,3
1,21.1,Dehydration,15862776,3
2,21.1,Pneumonia,15862776,1
3,21.1,Acute kidney injury,15862776,6
4,21.1,Prerenal failure,15862776,3
5,21.1,Enteritis infectious,15862776,6
0,21.1,Pruritus,15862779,
1,21.1,Oral surgery,15862779,
2,21.1,Therapy cessation,15862779,
0,21.1,Death,15862794,5
0,21.1,Hypersensitivity,15862798,1
0,21.1,Laboratory test abnormal,15862828,6
1,21.1,Nausea,15862828,6
2,21.1,Fatigue,15862828,6
3,21.1,Transfusion,15862828,6
4,21.1,Headache,15862828,6
5,21.1,Platelet count decreased,15862828,1
0,22.1,Product use issue,15862829,6
1,22.1,Drug interaction,15862829,2
2,22.1,Off label use,15862829,6
3,22.1,Proteinuria,15862829,1
4,22.1,Influenza like illness,15862829,6
5,22.1,Pyrexia,15862829,1
6,22.1,Hypotension,15862829,1
0,21.1,Death,15862839,
0,21.1,Pneumonitis,15862865,5
0,21.1,Neutrophil count decreased,15862874,1
1,21.1,Large intestine perforation,15862874,2
2,21.1,Fatigue,15862874,1
0,21.1,Lung carcinoma cell type unspecified recurrent,15862898,6
0,21.1,Disease progression,15862907,
0,21.1,Death,15862913,
0,21.1,Hepatic failure,15862916,5
1,21.1,Cough,15862916,6
2,21.1,Non-small cell lung cancer,15862916,5
0,21.1,Pulmonary oedema,15862994,6
0,21.1,Delirium,15862996,1
1,21.1,Diarrhoea,15862996,1
2,21.1,Functional gastrointestinal disorder,15862996,1
3,21.1,Gait inability,15862996,1
4,21.1,Anaemia,15862996,1
5,21.1,Malaise,15862996,1
0,21.1,Hypersensitivity,15862999,5
0,21.1,Pneumonia,15863004,3
1,21.1,Influenza,15863004,3
2,21.1,Pain,15863004,3
0,21.1,Pneumonia,15863028,6
1,21.1,Condition aggravated,15863028,6
0,21.1,Large intestine perforation,15863178,3
0,21.1,Prostate cancer,15863194,5
1,21.1,Disability,15863194,6
0,22.0,Carotid artery stenosis,15863195,1
1,22.0,Transient ischaemic attack,15863195,1
0,21.1,Death,15863196,5
0,21.1,Discomfort,15863204,3
1,21.1,Dysgraphia,15863204,6
2,21.1,Diarrhoea,15863204,1
3,21.1,Muscular weakness,15863204,3
4,21.1,Urinary tract infection,15863204,2
5,21.1,Hypersensitivity,15863204,3
6,21.1,Visual impairment,15863204,3
7,21.1,Peripheral swelling,15863204,3
8,21.1,Pain in extremity,15863204,3
9,21.1,Hypoaesthesia,15863204,6
10,21.1,Urticaria,15863204,3
11,21.1,Inflammation,15863204,3
12,21.1,Insomnia,15863204,6
0,22.1,General physical health deterioration,15863205,5
1,22.1,Mean cell volume increased,15863205,3
2,22.1,Haemoglobin urine present,15863205,3
3,22.1,Polychromasia,15863205,3
4,22.1,Blood albumin decreased,15863205,3
5,22.1,Nausea,15863205,3
6,22.1,Inappropriate schedule of product administration,15863205,6
7,22.1,Platelet count decreased,15863205,5
8,22.1,Mean cell haemoglobin increased,15863205,3
9,22.1,White blood cell count decreased,15863205,3
10,22.1,Neutrophil count decreased,15863205,3
11,22.1,Cough,15863205,3
12,22.1,Concomitant disease aggravated,15863205,3
13,22.1,Left atrial enlargement,15863205,6
14,22.1,Poor quality sleep,15863205,6
15,22.1,Haemothorax,15863205,6
16,22.1,Peripheral swelling,15863205,3
17,22.1,Anisocytosis,15863205,3
18,22.1,Rouleaux formation,15863205,3
19,22.1,Blood sodium increased,15863205,3
20,22.1,Haemoglobin decreased,15863205,6
21,22.1,Influenza,15863205,6
22,22.1,Blood pressure decreased,15863205,5
23,22.1,Blood pressure abnormal,15863205,6
24,22.1,Throat irritation,15863205,3
25,22.1,Blood lactate dehydrogenase increased,15863205,3
26,22.1,Oropharyngeal discomfort,15863205,6
27,22.1,Red blood cell count decreased,15863205,3
28,22.1,Gingival disorder,15863205,6
29,22.1,Poikilocytosis,15863205,3
30,22.1,Haematocrit decreased,15863205,3
31,22.1,Urinary tract infection,15863205,1
32,22.1,Feeling abnormal,15863205,5
33,22.1,Asthenia,15863205,5
34,22.1,Lymphocyte count decreased,15863205,3
35,22.1,Tremor,15863205,6
36,22.1,Nitrite urine present,15863205,3
37,22.1,Blood calcium decreased,15863205,3
38,22.1,Constipation,15863205,6
39,22.1,Vomiting,15863205,3
40,22.1,Urinary tract infection,15863205,1
41,22.1,Pneumonitis,15863205,5
42,22.1,Swelling,15863205,6
43,22.1,Abdominal distension,15863205,6
44,22.1,Abdominal pain,15863205,3
45,22.1,Red blood cell sedimentation rate increased,15863205,3
46,22.1,Blood thyroid stimulating hormone increased,15863205,3
47,22.1,Macrocytosis,15863205,3
48,22.1,Excessive granulation tissue,15863205,3
49,22.1,Elliptocytosis,15863205,3
50,22.1,Visual impairment,15863205,3
51,22.1,Gamma-glutamyltransferase increased,15863205,6
52,22.1,Fatigue,15863205,6
53,22.1,Red cell distribution width increased,15863205,3
54,22.1,Stomach mass,15863205,6
55,22.1,Nasopharyngitis,15863205,3
0,21.1,Aplastic anaemia,15863329,1
1,21.1,Pancytopenia,15863329,1
0,21.1,Disease progression,15863335,
0,22.1,Metastases to central nervous system,15863344,1
0,21.1,Disease progression,15863345,
0,21.1,Cholestasis,15863396,2
0,21.1,Meningioma,15863424,1
0,21.1,Decubitus ulcer,15863494,1
1,21.1,Hallucination,15863494,1
2,21.1,Product use in unapproved indication,15863494,6
0,22.0,Jejunostomy,15863510,6
1,22.0,Product use in unapproved indication,15863510,6
2,22.0,Gastrostomy,15863510,6
3,22.0,Nausea,15863510,6
4,22.0,Epigastric discomfort,15863510,6
5,22.0,Gastrointestinal haemorrhage,15863510,6
6,22.0,Gastric ulcer,15863510,6
0,22.1,Radiation pneumonitis,15863522,3
1,22.1,Interstitial lung disease,15863522,3
2,22.1,Pneumothorax,15863522,2
3,22.1,Malignant neoplasm progression,15863522,5
0,21.1,Radiation pneumonitis,15863523,6
0,21.1,Disease progression,15863559,
0,21.1,Blood creatinine increased,15863637,3
1,21.1,Blood potassium increased,15863637,3
0,22.0,Neuropathy peripheral,15863663,1
0,21.1,Pyrexia,15863665,2
1,21.1,Cholangitis,15863665,1
2,21.1,Jaundice cholestatic,15863665,1
3,21.1,Adrenocorticotropic hormone deficiency,15863665,3
4,21.1,Pneumonia,15863665,3
0,21.1,Vomiting,15863679,3
1,21.1,Pain in extremity,15863679,3
2,21.1,Nausea,15863679,3
3,21.1,Blood pressure increased,15863679,3
4,21.1,Malignant neoplasm progression,15863679,3
5,21.1,Fall,15863679,1
6,21.1,Rash generalised,15863679,3
7,21.1,Back pain,15863679,3
8,21.1,Arthralgia,15863679,3
9,21.1,Muscular weakness,15863679,3
10,21.1,Memory impairment,15863679,3
11,21.1,Rectal haemorrhage,15863679,3
12,21.1,Diarrhoea,15863679,3
13,21.1,Tumour pain,15863679,3
14,21.1,Myalgia,15863679,3
0,21.1,Nausea,15863722,2
1,21.1,Pyrexia,15863722,2
2,21.1,Dyspepsia,15863722,2
3,21.1,Neutropenia,15863722,2
0,21.1,Pancreatitis,15863731,
1,21.1,Arthralgia,15863731,
0,21.1,Nausea,15863854,3
1,21.1,Stomatitis,15863854,3
2,21.1,Constipation,15863854,3
3,21.1,Decreased appetite,15863854,3
0,21.1,Urine output increased,15863876,6
1,21.1,Anal incontinence,15863876,6
2,21.1,Anaesthesia,15863876,6
3,21.1,Metastasis,15863876,6
4,21.1,Urosepsis,15863876,6
5,21.1,Death,15863876,5
6,21.1,Spinal cord compression,15863876,6
0,21.1,Off label use,15863922,
1,21.1,Sepsis,15863922,
2,21.1,Product dose omission,15863922,6
3,21.1,Decreased appetite,15863922,6
0,22.0,Hepatocellular injury,15863950,1
0,21.1,Maternal exposure during pregnancy,15863975,6
1,21.1,Clostridium difficile infection,15863975,3
2,21.1,Shigella infection,15863975,3
0,21.1,Enteritis,15864002,1
1,21.1,Diarrhoea,15864002,1
0,21.1,Chills,15864019,1
1,21.1,Body temperature increased,15864019,1
2,21.1,Blood pressure increased,15864019,1
0,21.1,Death,15864026,
0,21.1,Interstitial lung disease,15864087,1
0,22.0,Mental status changes,15864141,6
1,22.0,Diabetic ketoacidosis,15864141,6
2,22.0,Nephropathy,15864141,6
3,22.0,Enteritis,15864141,6
0,21.1,Sensory disturbance,15864162,6
1,21.1,Drug intolerance,15864162,6
2,21.1,Anaemia,15864162,6
3,21.1,Fatigue,15864162,6
4,21.1,Restless legs syndrome,15864162,1
5,21.1,Gastrointestinal toxicity,15864162,1
6,21.1,Sleep deficit,15864162,6
0,21.1,Septic shock,15864203,5
1,21.1,Neutropenia,15864203,3
0,21.1,Rhabdomyolysis,15864241,6
0,21.1,Platelet count decreased,15864253,1
1,21.1,Death,15864253,5
2,21.1,Full blood count decreased,15864253,1
0,22.1,Muscular weakness,15864274,3
0,21.1,Product use in unapproved indication,15864342,6
1,21.1,Death,15864342,5
0,22.1,Respiratory failure,15864408,5
0,21.1,Endometrial cancer,15864519,
1,21.1,Product use in unapproved indication,15864519,
2,21.1,Off label use,15864519,
0,22.0,Hyperbilirubinaemia,15864527,1
1,22.0,Ascites,15864527,1
2,22.0,Malignant neoplasm progression,15864527,6
0,21.1,Dermatitis acneiform,15864528,1
1,21.1,Nausea,15864528,1
2,21.1,Stomatitis,15864528,1
3,21.1,Diarrhoea,15864528,1
4,21.1,Malignant neoplasm progression,15864528,5
5,21.1,Oedema peripheral,15864528,3
6,21.1,Paronychia,15864528,1
7,21.1,Febrile neutropenia,15864528,1
8,21.1,Dyskinesia,15864528,1
9,21.1,Pyrexia,15864528,1
0,21.1,Tongue haemorrhage,15864529,2
0,21.1,Deep vein thrombosis,15864531,6
1,21.1,Cardiac failure,15864531,1
2,21.1,Malignant neoplasm progression,15864531,6
3,21.1,Off label use,15864531,6
4,21.1,Condition aggravated,15864531,6
5,21.1,Atrial fibrillation,15864531,1
6,21.1,Haemoptysis,15864531,6
7,21.1,Diarrhoea,15864531,6
8,21.1,Hypokalaemia,15864531,6
9,21.1,Mucosal inflammation,15864531,6
0,21.1,Hepatitis B reactivation,15864536,1
0,21.1,Fatigue,15864559,6
1,21.1,Death,15864559,5
2,21.1,Laboratory test abnormal,15864559,6
0,21.1,Palmar-plantar erythrodysaesthesia syndrome,15864567,6
1,21.1,Platelet count decreased,15864567,6
2,21.1,Hypertransaminasaemia,15864567,6
0,21.1,Inappropriate schedule of product administration,15864572,6
1,21.1,Death,15864572,5
0,21.1,Hyponatraemia,15864592,1
0,21.1,Diverticulitis,15864616,
1,21.1,Large intestine perforation,15864616,
0,21.1,Hypersomnia,15864619,
1,21.1,Anal incontinence,15864619,
2,21.1,Exercise tolerance decreased,15864619,2
3,21.1,Hypertension,15864619,
4,21.1,Iron deficiency anaemia,15864619,
5,21.1,Diarrhoea,15864619,2
6,21.1,Somnolence,15864619,
7,21.1,Fatigue,15864619,
8,21.1,Blister,15864619,
9,21.1,Confusional state,15864619,
10,21.1,Colon cancer,15864619,
11,21.1,Musculoskeletal stiffness,15864619,
12,21.1,Muscular weakness,15864619,
13,21.1,Unresponsive to stimuli,15864619,
14,21.1,Asthenia,15864619,2
15,21.1,Urinary tract infection,15864619,
16,21.1,Dysphonia,15864619,
17,21.1,Pain in extremity,15864619,2
18,21.1,Fatigue,15864619,
19,21.1,Hospitalisation,15864619,
20,21.1,Pain in extremity,15864619,
21,21.1,Amnesia,15864619,
22,21.1,Product administration error,15864619,
23,21.1,Diarrhoea,15864619,
24,21.1,Fall,15864619,
0,22.1,Fall,15864705,6
1,22.1,Vomiting,15864705,1
2,22.1,Acute kidney injury,15864705,1
3,22.1,Hyperkalaemia,15864705,1
4,22.1,Nausea,15864705,1
5,22.1,Lactic acidosis,15864705,1
0,21.1,Blood creatinine increased,15864741,6
1,21.1,Neutropenic sepsis,15864741,5
2,21.1,Diarrhoea,15864741,6
3,21.1,Blood urea increased,15864741,6
4,21.1,White blood cell count decreased,15864741,6
5,21.1,Haemoglobin decreased,15864741,6
6,21.1,Pyrexia,15864741,6
7,21.1,Stomatitis,15864741,6
8,21.1,Skin hyperpigmentation,15864741,6
0,21.1,General physical health deterioration,15864744,6
1,21.1,Seizure,15864744,1
2,21.1,Dysarthria,15864744,1
0,22.0,Productive cough,15864849,1
1,22.0,Gastrostomy,15864849,3
2,22.0,Epistaxis,15864849,1
3,22.0,Hypertension,15864849,1
4,22.0,Dyspnoea,15864849,1
5,22.0,Mouth haemorrhage,15864849,1
6,22.0,Tracheal haemorrhage,15864849,1
7,22.0,Headache,15864849,1
0,21.1,Rash,15864858,6
0,21.1,Depression suicidal,15864915,1
1,21.1,Hot flush,15864915,1
2,21.1,Bone pain,15864915,1
3,21.1,Musculoskeletal stiffness,15864915,1
0,21.1,Lacunar infarction,15864916,6
0,21.1,Respiratory distress,15864918,1
1,21.1,Pneumonitis,15864918,1
0,21.1,Death,15864972,5
1,21.1,Brain neoplasm,15864972,3
2,21.1,Hypotension,15864972,6
3,21.1,Localised infection,15864972,6
4,21.1,Urinary tract infection,15864972,6
0,22.0,Respiratory tract infection,15865243,1
0,22.0,Dehydration,15865266,1
1,22.0,Asthenia,15865266,1
0,21.1,Adverse event,15865310,6
1,21.1,Product use in unapproved indication,15865310,6
0,21.1,Diarrhoea,15865380,6
1,21.1,Thrombocytopenia,15865380,6
2,21.1,Peripheral sensory neuropathy,15865380,6
3,21.1,Neutropenia,15865380,6
4,21.1,Atrial fibrillation,15865380,6
5,21.1,Body temperature increased,15865380,6
6,21.1,Fatigue,15865380,6
7,21.1,Constipation,15865380,6
8,21.1,Palmar-plantar erythrodysaesthesia syndrome,15865380,6
9,21.1,Benign prostatic hyperplasia,15865380,6
10,21.1,Jugular vein thrombosis,15865380,1
0,22.1,Leukopenia,15865470,1
1,22.1,Neutropenia,15865470,1
2,22.1,Bone pain,15865470,6
0,21.1,Sepsis,15865502,3
1,21.1,Pleural effusion,15865502,2
2,21.1,Deep vein thrombosis,15865502,2
0,21.1,Haemoglobin decreased,15865509,2
0,22.0,Febrile bone marrow aplasia,15865540,1
1,22.0,Diarrhoea,15865540,1
0,22.0,Febrile neutropenia,15865551,5
0,21.1,Neuropathy peripheral,15865562,3
0,22.0,Nausea,15865595,1
0,22.0,Malignant neoplasm progression,15865623,6
1,22.0,Diarrhoea,15865623,1
2,22.0,Bone abscess,15865623,1
3,22.0,Diverticular perforation,15865623,1
0,21.1,Bone marrow failure,15865634,3
0,21.1,Blood testosterone increased,15865696,6
0,22.1,Interstitial lung disease,15865744,5
1,22.1,Pneumothorax,15865744,3
0,21.1,Organising pneumonia,15865748,1
1,21.1,Malignant neoplasm progression,15865748,5
0,21.1,Hypotension,15865753,3
1,21.1,Prerenal failure,15865753,3
2,21.1,Acute kidney injury,15865753,6
3,21.1,Pneumonia,15865753,1
4,21.1,Enteritis infectious,15865753,6
5,21.1,Dehydration,15865753,3
6,21.1,Overdose,15865753,6
0,21.1,Product use in unapproved indication,15865759,6
1,21.1,Adverse event,15865759,1
0,21.1,Dry mouth,15865808,6
0,21.1,Cardiac failure,15865861,6
1,21.1,Ejection fraction decreased,15865861,6
0,22.0,Metastases to lung,15865883,6
1,22.0,Malignant neoplasm progression,15865883,6
2,22.0,Pulmonary toxicity,15865883,5
0,21.1,Hypoacusis,15865891,3
1,21.1,Tinnitus,15865891,3
0,22.1,Small intestinal perforation,15865959,5
0,21.1,Cholangitis sclerosing,15865981,1
0,22.0,Drug intolerance,15866011,3
1,22.0,Vomiting,15866011,6
2,22.0,Asthenia,15866011,3
3,22.0,Gastric disorder,15866011,6
4,22.0,Dyspepsia,15866011,6
5,22.0,Nausea,15866011,1
6,22.0,Malaise,15866011,6
7,22.0,Inappropriate schedule of product administration,15866011,3
8,22.0,Secretion discharge,15866011,6
9,22.0,Toxicity to various agents,15866011,6
10,22.0,Dehydration,15866011,6
11,22.0,Cancer pain,15866011,6
12,22.0,Decreased appetite,15866011,6
13,22.0,Blood glucose increased,15866011,6
14,22.0,Oropharyngeal pain,15866011,6
15,22.0,Vomiting,15866011,1
16,22.0,Dysgeusia,15866011,3
17,22.0,Weight decreased,15866011,6
18,22.0,Fatigue,15866011,6
19,22.0,Product administration error,15866011,6
0,21.1,Progressive multifocal leukoencephalopathy,15866026,6
0,21.1,Application site haemorrhage,15866032,6
1,21.1,Breast cancer metastatic,15866032,3
0,21.1,Hypopituitarism,15866052,1
0,21.1,Hypertension,15866075,3
1,21.1,Pyrexia,15866075,1
0,22.0,Road traffic accident,15866216,2
1,22.0,Stress,15866216,6
2,22.0,Influenza,15866216,6
3,22.0,Neoplasm progression,15866216,6
0,22.1,Back pain,15866220,6
1,22.1,Confusional state,15866220,6
2,22.1,Nasopharyngitis,15866220,6
3,22.1,Laryngitis,15866220,6
4,22.1,Eating disorder,15866220,6
5,22.1,Neoplasm progression,15866220,6
6,22.1,Gait disturbance,15866220,6
0,21.1,Alopecia,15866223,3
1,21.1,Madarosis,15866223,3
0,21.1,Pleural effusion,15866245,6
1,21.1,Product use in unapproved indication,15866245,6
0,22.0,Fatigue,15866267,3
1,22.0,Memory impairment,15866267,1
2,22.0,Disturbance in attention,15866267,1
0,21.1,Pain of skin,15866269,6
1,21.1,Alopecia,15866269,6
2,21.1,Throat irritation,15866269,6
3,21.1,Oral mucosal blistering,15866269,6
4,21.1,Fatigue,15866269,6
0,22.1,Alopecia,15866275,3
0,22.0,Cough,15866296,6
1,22.0,Pyrexia,15866296,6
2,22.0,Dysgeusia,15866296,6
3,22.0,Oropharyngeal pain,15866296,6
4,22.0,Nausea,15866296,3
5,22.0,Respiratory tract infection,15866296,6
6,22.0,Rhinorrhoea,15866296,6
7,22.0,White blood cell count decreased,15866296,6
8,22.0,Influenza,15866296,6
9,22.0,Oral pain,15866296,6
10,22.0,Full blood count decreased,15866296,6
11,22.0,Fatigue,15866296,3
0,21.1,Hair disorder,15866320,3
1,21.1,Mental disorder,15866320,6
2,21.1,Hair texture abnormal,15866320,3
3,21.1,Madarosis,15866320,3
4,21.1,Hair colour changes,15866320,3
5,21.1,Alopecia,15866320,3
0,22.0,Alopecia,15866331,3
1,22.0,Hair disorder,15866331,3
2,22.0,Hair texture abnormal,15866331,3
3,22.0,Madarosis,15866331,3
4,22.0,Hair colour changes,15866331,3
0,21.1,Madarosis,15866337,1
1,21.1,Hair disorder,15866337,3
2,21.1,Hair texture abnormal,15866337,3
3,21.1,Alopecia,15866337,3
4,21.1,Hair colour changes,15866337,3
0,22.0,Alopecia,15866338,3
1,22.0,Hair disorder,15866338,3
2,22.0,Hair texture abnormal,15866338,3
3,22.0,Hair colour changes,15866338,3
0,21.1,Alopecia,15866354,3
1,21.1,Hair texture abnormal,15866354,3
2,21.1,Hair colour changes,15866354,3
3,21.1,Hair disorder,15866354,3
4,21.1,Madarosis,15866354,3
0,22.0,Pyrexia,15866364,1
1,22.0,Liver function test abnormal,15866364,1
0,21.1,Hair disorder,15866374,3
1,21.1,Hair texture abnormal,15866374,3
2,21.1,Madarosis,15866374,3
3,21.1,Alopecia,15866374,3
4,21.1,Hair colour changes,15866374,3
0,22.0,Feeling abnormal,15866381,2
1,22.0,Alopecia,15866381,1
2,22.0,Arthralgia,15866381,1
3,22.0,White blood cell count abnormal,15866381,3
4,22.0,Myalgia,15866381,1
5,22.0,Insomnia,15866381,1
0,22.0,Glaucoma,15866389,6
1,22.0,White blood cell count decreased,15866389,1
2,22.0,Body height decreased,15866389,6
3,22.0,Red blood cell count decreased,15866389,6
4,22.0,Alopecia,15866389,3
0,21.1,Pneumonia viral,15866429,1
1,21.1,Anaemia,15866429,6
2,21.1,Lactic acidosis,15866429,6
0,21.1,Alopecia,15866431,3
0,22.0,Alopecia,15866446,3
1,22.0,Hair disorder,15866446,3
2,22.0,Hair colour changes,15866446,3
3,22.0,Madarosis,15866446,3
4,22.0,Hair texture abnormal,15866446,3
0,22.0,Alopecia,15866535,3
1,22.0,Hair disorder,15866535,3
2,22.0,Hair texture abnormal,15866535,3
3,22.0,Hair colour changes,15866535,3
4,22.0,Madarosis,15866535,3
0,21.1,Hair texture abnormal,15866633,3
1,21.1,Hair colour changes,15866633,3
2,21.1,Hair disorder,15866633,3
3,21.1,Madarosis,15866633,3
4,21.1,Alopecia,15866633,3
0,21.1,Menopause,15866647,6
0,21.1,Procedural complication,15866738,5
0,21.1,Hypertension,15866792,2
1,21.1,Electrocardiogram QT prolonged,15866792,1
0,21.1,Diarrhoea,15866830,
0,22.0,Febrile neutropenia,15866842,1
1,22.0,Dehydration,15866842,1
0,21.1,Mouth ulceration,15866872,1
1,21.1,Rash maculo-papular,15866872,2
2,21.1,Skin fissures,15866872,1
0,22.0,Acute kidney injury,15866887,6
0,21.1,Drug ineffective,15866949,6
1,21.1,Prostate cancer recurrent,15866949,6
2,21.1,Prostate cancer,15866949,6
3,21.1,Malignant neoplasm progression,15866949,6
0,21.1,Drug ineffective,15866951,6
1,21.1,Gastrointestinal haemorrhage,15866951,6
2,21.1,Pleural effusion,15866951,6
0,21.1,Dry skin,15866960,
1,21.1,Skin fissures,15866960,
0,21.1,Vomiting,15866961,1
1,21.1,Pulmonary embolism,15866961,3
0,21.1,Anaemia,15866962,3
1,21.1,Pelvic abscess,15866962,1
0,21.1,Leukopenia,15866963,1
1,21.1,Neutropenia,15866963,1
2,21.1,Respiratory tract infection,15866963,1
0,21.1,Enterocolitis,15866970,1
1,21.1,Alanine aminotransferase increased,15866970,1
2,21.1,Off label use,15866970,6
0,21.1,Thrombocytopenia,15866991,3
1,21.1,Off label use,15866991,6
2,21.1,Metabolic acidosis,15866991,2
3,21.1,Acute kidney injury,15866991,3
0,21.1,Hyponatraemia,15866997,6
1,21.1,Proteinuria,15866997,6
2,21.1,Brain oedema,15866997,6
3,21.1,Polycythaemia,15866997,6
4,21.1,Blood lactic acid increased,15866997,6
5,21.1,Blood creatine phosphokinase increased,15866997,6
6,21.1,Electrocardiogram abnormal,15866997,6
7,21.1,Subarachnoid haemorrhage,15866997,6
8,21.1,Leukocytosis,15866997,6
9,21.1,Epilepsy,15866997,6
10,21.1,Pyrexia,15866997,6
11,21.1,Brain contusion,15866997,6
12,21.1,Sinus tachycardia,15866997,6
13,21.1,C-reactive protein increased,15866997,6
0,21.1,Type I hypersensitivity,15867000,1
1,21.1,Febrile neutropenia,15867000,1
0,21.1,Anaphylactic shock,15867003,1
0,21.1,Cerebral infarction,15867006,2
0,21.1,Anaphylactic reaction,15867008,1
0,21.1,Retinal disorder,15867011,6
0,21.1,Colitis,15867013,1
1,21.1,Neuropathy peripheral,15867013,3
2,21.1,Tremor,15867013,4
0,21.1,Malignant neoplasm progression,15867041,6
1,21.1,Product use issue,15867041,6
0,21.1,Myocarditis,15867052,2
1,21.1,Cardiac failure acute,15867052,1
2,21.1,Ejection fraction decreased,15867052,2
0,21.1,Gastric ulcer,15867057,6
1,21.1,Duodenal ulcer,15867057,6
0,21.1,Rheumatic disorder,15867074,2
1,21.1,Malignant neoplasm progression,15867074,6
0,21.1,Blood glucose increased,15867095,6
1,21.1,White blood cell count decreased,15867095,6
2,21.1,Weight increased,15867095,6
3,21.1,Metastases to liver,15867095,6
4,21.1,Red blood cell count decreased,15867095,6
5,21.1,Tumour marker increased,15867095,6
6,21.1,Thyroid cancer,15867095,6
7,21.1,Oedema peripheral,15867095,6
8,21.1,Alopecia,15867095,6
9,21.1,Kyphosis,15867095,6
10,21.1,Fatigue,15867095,2
11,21.1,Pain,15867095,6
12,21.1,Peripheral venous disease,15867095,6
13,21.1,Lymphoedema,15867095,6
14,21.1,Urinary tract infection,15867095,6
0,21.1,Rheumatic disorder,15867151,1
1,21.1,Malignant neoplasm progression,15867151,6
0,21.1,Rheumatic disorder,15867176,1
0,21.1,Malignant neoplasm progression,15867254,6
1,21.1,Rheumatic disorder,15867254,2
0,22.0,Renal failure,15867289,6
1,22.0,Chronic kidney disease,15867289,3
0,22.1,Deafness,15867314,6
1,22.1,Syncope,15867314,6
2,22.1,Blood pressure decreased,15867314,6
3,22.1,Dizziness,15867314,6
4,22.1,Weight decreased,15867314,6
5,22.1,Nasopharyngitis,15867314,6
6,22.1,Heart rate increased,15867314,6
7,22.1,Hypoglycaemia,15867314,6
8,22.1,Diarrhoea,15867314,6
9,22.1,Fall,15867314,6
10,22.1,Insomnia,15867314,6
11,22.1,Pyrexia,15867314,6
12,22.1,Headache,15867314,6
13,22.1,Dry skin,15867314,6
14,22.1,Blood pressure increased,15867314,6
0,21.1,Malignant neoplasm progression,15867329,6
1,21.1,Purpura,15867329,2
0,22.0,Anaemia,15867369,6
1,22.0,Hypoglycaemia,15867369,6
2,22.0,Urinary retention,15867369,6
3,22.0,Product use in unapproved indication,15867369,6
4,22.0,Malignant neoplasm progression,15867369,6
5,22.0,Renal failure,15867369,6
6,22.0,Haematuria,15867369,6
7,22.0,Arthralgia,15867369,6
8,22.0,Herpes zoster,15867369,6
0,21.1,Drug resistance,15867376,6
1,21.1,Acquired gene mutation,15867376,6
2,21.1,Nausea,15867376,6
3,21.1,Fatigue,15867376,6
0,21.1,Small intestinal obstruction,15867407,6
1,21.1,Dysgeusia,15867407,6
2,21.1,Fatigue,15867407,6
3,21.1,Nausea,15867407,3
0,21.1,Pneumonia,15867459,2
0,21.1,Gastric disorder,15867493,6
1,21.1,Yellow skin,15867493,6
2,21.1,Malaise,15867493,6
3,21.1,Sepsis,15867493,6
0,21.1,Pancreatitis,15867527,6
1,21.1,Cholelithiasis,15867527,6
0,22.1,Neoplasm progression,15867533,6
1,22.1,Fatigue,15867533,3
2,22.1,Feeling abnormal,15867533,6
3,22.1,Thrombosis,15867533,6
0,21.1,White blood cell count decreased,15867546,6
0,22.0,Hair disorder,15867562,3
1,22.0,Madarosis,15867562,3
2,22.0,Alopecia,15867562,3
3,22.0,Hair texture abnormal,15867562,3
4,22.0,Hair colour changes,15867562,3
5,22.0,Depression,15867562,6
0,21.1,Hepatic enzyme abnormal,15867599,6
1,21.1,Fatigue,15867599,3
2,21.1,Herpes zoster,15867599,6
3,21.1,Pyrexia,15867599,6
4,21.1,Blood pressure increased,15867599,3
0,21.1,Constipation,15867601,2
1,21.1,Hyperaesthesia,15867601,
2,21.1,Anal fissure,15867601,
3,21.1,Haemorrhoids,15867601,
4,21.1,Off label use,15867601,
0,21.1,Interstitial lung disease,15867611,5
1,21.1,Influenza,15867611,2
0,21.1,Neutropenia,15867615,1
1,21.1,Thrombocytopenia,15867615,1
2,21.1,Drug ineffective,15867615,6
0,22.0,Hair texture abnormal,15867628,3
1,22.0,Hair colour changes,15867628,3
2,22.0,Madarosis,15867628,3
3,22.0,Alopecia,15867628,3
4,22.0,Hair disorder,15867628,3
0,21.1,Hydronephrosis,15867631,6
1,21.1,Haematuria,15867631,1
0,22.0,Constipation,15867637,3
1,22.0,Nausea,15867637,2
2,22.0,Red blood cell count decreased,15867637,2
3,22.0,Neutropenia,15867637,6
4,22.0,Gastric cancer,15867637,6
5,22.0,Full blood count decreased,15867637,6
6,22.0,Fatigue,15867637,2
7,22.0,Peripheral swelling,15867637,6
8,22.0,Second primary malignancy,15867637,6
9,22.0,Insomnia,15867637,6
10,22.0,Leukopenia,15867637,6
11,22.0,Joint swelling,15867637,6
0,21.1,Febrile neutropenia,15867660,6
0,21.1,Rhabdomyolysis,15867798,1
1,21.1,Muscular weakness,15867798,1
2,21.1,C-reactive protein increased,15867798,
3,21.1,Thyroid cancer,15867798,5
4,21.1,Myalgia,15867798,1
5,21.1,Decreased appetite,15867798,1
6,21.1,Myoglobinuria,15867798,1
7,21.1,Pain in extremity,15867798,1
8,21.1,Delirium,15867798,1
9,21.1,Hepatic enzyme increased,15867798,
10,21.1,Blood creatine phosphokinase increased,15867798,1
0,21.1,Pulmonary embolism,15867802,5
1,21.1,Malignant neoplasm progression,15867802,5
0,21.1,Malaise,15867828,6
0,21.1,Neutropenia,15867857,2
1,21.1,Thrombocytopenia,15867857,2
2,21.1,Petechiae,15867857,2
0,22.1,Pancytopenia,15867877,5
0,21.1,Metastases to bone,15867903,6
1,21.1,Metastases to liver,15867903,6
0,21.1,Gastrointestinal haemorrhage,15867940,1
0,21.1,Pulmonary oedema,15867966,5
0,22.0,Polyneuropathy,15868025,3
1,22.0,Influenza like illness,15868025,1
2,22.0,Paraneoplastic syndrome,15868025,1
3,22.0,Neoplasm progression,15868025,6
4,22.0,Renal failure,15868025,1
5,22.0,Febrile infection,15868025,1
6,22.0,Pulmonary embolism,15868025,2
7,22.0,Febrile infection,15868025,1
8,22.0,Death,15868025,5
9,22.0,Blood creatinine increased,15868025,1
0,21.1,Hydronephrosis,15868090,1
0,22.0,Product use in unapproved indication,15868097,6
1,22.0,Anaphylactic reaction,15868097,2
2,22.0,Off label use,15868097,6
0,21.1,Death,15868099,5
0,21.1,Hypokalaemia,15868105,1
1,21.1,Hyponatraemia,15868105,1
2,21.1,Syncope,15868105,1
0,21.1,Treatment failure,15868157,
1,21.1,Adverse drug reaction,15868157,
0,22.1,Hypothyroidism,15868159,6
1,22.1,Thyroiditis,15868159,6
2,22.1,Bone marrow failure,15868159,6
0,21.1,Malignant neoplasm progression,15868161,5
1,21.1,Dysphagia,15868161,6
2,21.1,Malaise,15868161,3
0,21.1,Therapy cessation,15868164,
1,21.1,Surgery,15868164,
0,21.1,Encephalitis,15868177,1
0,21.1,Surgery,15868196,
0,21.1,Secondary adrenocortical insufficiency,15868223,4
1,21.1,Fulminant type 1 diabetes mellitus,15868223,4
2,21.1,Adrenal disorder,15868223,6
3,21.1,Fall,15868223,6
4,21.1,Type 1 diabetes mellitus,15868223,6
5,21.1,Delirium,15868223,6
6,21.1,Spinal compression fracture,15868223,6
0,22.1,Dry skin,15868233,6
1,22.1,Weight decreased,15868233,6
2,22.1,Dizziness,15868233,6
3,22.1,Palmar-plantar erythrodysaesthesia syndrome,15868233,1
4,22.1,Pruritus,15868233,6
5,22.1,Arthralgia,15868233,1
6,22.1,Abscess,15868233,1
0,21.1,Pyrexia,15868242,
1,21.1,Hyperhidrosis,15868242,
2,21.1,Vaginal discharge,15868242,
3,21.1,Weight decreased,15868242,
4,21.1,Asthenia,15868242,
5,21.1,Endometrial disorder,15868242,
6,21.1,Vulvovaginal burning sensation,15868242,
7,21.1,Polyp,15868242,
8,21.1,Chills,15868242,
9,21.1,Nephrolithiasis,15868242,
10,21.1,Rectal fissure,15868242,
0,21.1,Metastases to peritoneum,15868245,6
1,21.1,Intestinal perforation,15868245,4
0,21.1,Death,15868251,
0,21.1,Rheumatic disorder,15868253,1
0,21.1,Adverse event,15868270,6
0,21.1,Psoriatic arthropathy,15868272,2
0,21.1,Dysphonia,15868273,3
0,21.1,Peripheral swelling,15868281,
1,21.1,Stomatitis,15868281,
2,21.1,Blister,15868281,
3,21.1,Thrombosis,15868281,
4,21.1,Gait inability,15868281,
0,21.1,Death,15868290,
0,21.1,Gait inability,15868324,
1,21.1,Tachycardia,15868324,
2,21.1,Coordination abnormal,15868324,
3,21.1,Blister,15868324,
4,21.1,Pain in extremity,15868324,
5,21.1,Cardiomegaly,15868324,
6,21.1,Asthenia,15868324,
0,21.1,Product use in unapproved indication,15868330,1
1,21.1,Second primary malignancy,15868330,1
2,21.1,Blastic plasmacytoid dendritic cell neoplasia,15868330,1
0,21.1,Neoplasm progression,15868339,6
1,21.1,Palmar-plantar erythrodysaesthesia syndrome,15868339,6
0,21.1,Death,15868340,5
1,21.1,Cardiovascular disorder,15868340,6
2,21.1,Electrocardiogram QT prolonged,15868340,6
3,21.1,General physical health deterioration,15868340,6
0,21.1,Blood bilirubin increased,15868352,1
1,21.1,Ascites,15868352,
2,21.1,Off label use,15868352,
3,21.1,Blood bilirubin increased,15868352,
0,21.1,Cardiac failure,15868361,5
0,21.1,Mobility decreased,15868375,6
1,21.1,Motor dysfunction,15868375,6
2,21.1,Asthenia,15868375,6
3,21.1,Pain,15868375,6
4,21.1,Prostate cancer metastatic,15868375,5
0,21.1,Death,15868386,
0,21.1,Dizziness,15868395,
1,21.1,Palmar-plantar erythrodysaesthesia syndrome,15868395,
2,21.1,Fatigue,15868395,
0,22.0,Malignant neoplasm progression,15868402,5
1,22.0,Dehydration,15868402,2
2,22.0,Acute kidney injury,15868402,2
3,22.0,Hypercalcaemia,15868402,2
4,22.0,Decreased appetite,15868402,2
0,22.0,Interstitial lung disease,15868465,2
1,22.0,Rash,15868465,1
0,21.1,Thrombocytopenia,15868476,6
1,21.1,Gamma-glutamyltransferase increased,15868476,6
2,21.1,Leukopenia,15868476,6
3,21.1,Blood lactate dehydrogenase increased,15868476,6
0,21.1,Death,15868477,5
1,21.1,Disease progression,15868477,5
2,21.1,Drug ineffective,15868477,3
0,21.1,Acute hepatic failure,15868488,5
1,21.1,Death,15868488,5
0,21.1,Metastases to lung,15868489,6
1,21.1,Disease progression,15868489,6
0,21.1,Nausea,15868494,1
1,21.1,Feeling hot,15868494,1
2,21.1,Erythema,15868494,1
3,21.1,Pruritus,15868494,1
4,21.1,Dyspnoea,15868494,1
5,21.1,Hypotension,15868494,1
0,21.1,Impaired healing,15868495,3
1,21.1,Malignant neoplasm progression,15868495,5
2,21.1,Pneumothorax,15868495,6
0,21.1,Rheumatic disorder,15868496,2
0,22.1,Hepatic failure,15868526,1
1,22.1,Tumour hyperprogression,15868526,1
2,22.1,Colorectal cancer metastatic,15868526,5
0,21.1,Disease progression,15868554,5
1,21.1,Fatigue,15868554,2
0,22.0,Nausea,15868567,6
1,22.0,Gastrointestinal stoma complication,15868567,6
2,22.0,Abdominal pain,15868567,6
3,22.0,Vomiting,15868567,6
4,22.0,Burning sensation,15868567,6
0,21.1,Disseminated intravascular coagulation,15868570,5
1,21.1,C-reactive protein increased,15868570,5
2,21.1,Liver function test increased,15868570,5
3,21.1,Platelet count decreased,15868570,5
4,21.1,Fibrin D dimer increased,15868570,5
0,21.1,Dermatitis bullous,15868620,1
0,21.1,Death,15868624,5
0,21.1,Nocturia,15868633,1
1,21.1,Therapy cessation,15868633,1
2,21.1,Hypertension,15868633,1
3,21.1,Off label use,15868633,1
4,21.1,Product use in unapproved indication,15868633,1
5,21.1,Visual impairment,15868633,1
0,21.1,Colon cancer metastatic,15868656,
1,21.1,Disease progression,15868656,5
0,22.0,Influenza,15868667,1
0,21.1,Malignant neoplasm progression,15868674,6
1,21.1,Nausea,15868674,6
2,21.1,Acquired gene mutation,15868674,6
3,21.1,Drug resistance,15868674,6
0,21.1,Death,15868757,5
0,21.1,Pruritus allergic,15868768,1
0,21.1,Death,15868793,5
0,21.1,Respiratory failure,15868800,5
0,21.1,Rheumatic disorder,15868822,2
0,22.0,Pancytopenia,15868830,1
0,21.1,Fatigue,15868978,3
1,21.1,Pleural effusion,15868978,5
2,21.1,Joint effusion,15868978,3
3,21.1,Joint swelling,15868978,3
4,21.1,Dyspnoea,15868978,3
5,21.1,Peripheral swelling,15868978,3
6,21.1,Weight increased,15868978,3
7,21.1,Cough,15868978,3
8,21.1,Peripheral swelling,15868978,6
9,21.1,Diarrhoea,15868978,6
0,21.1,Drug resistance,15868984,6
1,21.1,Malignant neoplasm progression,15868984,6
2,21.1,Acquired gene mutation,15868984,6
0,21.1,Neutropenia,15868986,1
0,21.1,Transfusion,15869048,6
0,22.1,Leukopenia,15869101,1
1,22.1,Cough,15869101,1
0,21.1,Haemorrhage,15869215,3
0,21.1,Anaemia,15869232,2
1,21.1,Leukopenia,15869232,1
2,21.1,Hyperkalaemia,15869232,5
0,22.0,Myalgia,15869238,3
1,22.0,Tachycardia,15869238,3
2,22.0,Neuropathy peripheral,15869238,3
3,22.0,Hot flush,15869238,3
4,22.0,Fatigue,15869238,1
5,22.0,Carbohydrate antigen 125 increased,15869238,3
6,22.0,Anxiety,15869238,6
7,22.0,Constipation,15869238,2
8,22.0,Arthralgia,15869238,3
9,22.0,Nausea,15869238,3
10,22.0,Rash,15869238,3
11,22.0,Product dose omission,15869238,6
12,22.0,Pain,15869238,3
13,22.0,Computerised tomogram abnormal,15869238,6
14,22.0,Headache,15869238,3
0,21.1,Inappropriate schedule of product administration,15869245,6
1,21.1,Death,15869245,5
0,21.1,Dyspnoea,15869251,1
1,21.1,Febrile neutropenia,15869251,1
2,21.1,Cardiac failure,15869251,1
3,21.1,Pneumonia,15869251,1
0,21.1,Mouth breathing,15869266,6
1,21.1,Peripheral artery thrombosis,15869266,3
2,21.1,Metastases to lung,15869266,5
3,21.1,Metastases to liver,15869266,5
4,21.1,Metastases to bone,15869266,5
5,21.1,General physical health deterioration,15869266,6
6,21.1,Cardiac arrest,15869266,5
7,21.1,Hepatic failure,15869266,5
8,21.1,Blood pressure decreased,15869266,6
9,21.1,Oliguria,15869266,6
10,21.1,Metastases to lymph nodes,15869266,5
11,21.1,Depressed level of consciousness,15869266,6
12,21.1,Off label use,15869266,6
13,21.1,Metastases to peritoneum,15869266,5
14,21.1,Hepatomegaly,15869266,6
0,21.1,Confusional state,15869267,6
0,21.1,Coronary artery occlusion,15869280,
0,21.1,Disease progression,15869295,5
1,21.1,Thrombocytopenia,15869295,1
2,21.1,Oral pain,15869295,3
3,21.1,Gait inability,15869295,6
4,21.1,Fall,15869295,6
5,21.1,Vomiting,15869295,1
6,21.1,Haemoglobin decreased,15869295,3
7,21.1,Petechiae,15869295,3
8,21.1,Haematocrit decreased,15869295,1
9,21.1,Pulse abnormal,15869295,3
10,21.1,Hypotension,15869295,6
11,21.1,Platelet count decreased,15869295,1
12,21.1,Peripheral swelling,15869295,3
13,21.1,Skin ulcer,15869295,6
14,21.1,Contusion,15869295,1
15,21.1,Nausea,15869295,2
16,21.1,Dizziness,15869295,3
17,21.1,Anaemia,15869295,1
18,21.1,Urinary incontinence,15869295,6
19,21.1,Weight decreased,15869295,3
20,21.1,Asthenia,15869295,3
21,21.1,Dehydration,15869295,1
22,21.1,Diarrhoea,15869295,1
23,21.1,Fatigue,15869295,3
24,21.1,Constipation,15869295,1
25,21.1,Decreased appetite,15869295,3
26,21.1,Red blood cell count decreased,15869295,3
0,21.1,Somnolence,15869348,3
1,21.1,Back pain,15869348,3
2,21.1,Fatigue,15869348,1
3,21.1,Blood pressure fluctuation,15869348,2
4,21.1,Nephrolithiasis,15869348,6
5,21.1,Diarrhoea,15869348,3
6,21.1,Urosepsis,15869348,6
7,21.1,Pain in extremity,15869348,3
8,21.1,Arthralgia,15869348,3
9,21.1,Hypotension,15869348,3
10,21.1,Amnesia,15869348,2
11,21.1,Dysgeusia,15869348,3
12,21.1,Pneumonia,15869348,6
13,21.1,Tremor,15869348,3
14,21.1,Confusional state,15869348,2
15,21.1,Skin exfoliation,15869348,3
16,21.1,Irritability,15869348,3
17,21.1,Dizziness,15869348,1
18,21.1,Renal impairment,15869348,3
19,21.1,Dehydration,15869348,1
20,21.1,Dysstasia,15869348,3
21,21.1,Malignant neoplasm progression,15869348,3
0,21.1,Bone pain,15869349,3
1,21.1,Hypotension,15869349,3
2,21.1,Dizziness,15869349,3
3,21.1,Chest discomfort,15869349,3
4,21.1,Arteriosclerosis,15869349,3
5,21.1,Asthenia,15869349,3
6,21.1,Gait inability,15869349,3
7,21.1,Fatigue,15869349,6
8,21.1,Exostosis,15869349,3
9,21.1,Intentional dose omission,15869349,6
10,21.1,Feeling abnormal,15869349,3
0,22.0,Prostate cancer metastatic,15869353,3
1,22.0,Abdominal mass,15869353,3
2,22.0,Abdominal pain,15869353,3
0,21.1,Shock,15869385,6
1,21.1,Depression,15869385,6
2,21.1,Hypoxia,15869385,6
3,21.1,Anaemia,15869385,6
4,21.1,Malignant neoplasm progression,15869385,6
5,21.1,Acute kidney injury,15869385,6
6,21.1,Diarrhoea,15869385,6
7,21.1,Bronchitis,15869385,6
8,21.1,Clostridium difficile colitis,15869385,1
9,21.1,Cholelithiasis,15869385,6
0,21.1,Headache,15869418,3
1,21.1,Metastases to central nervous system,15869418,3
2,21.1,Vision blurred,15869418,3
3,21.1,Lethargy,15869418,6
4,21.1,Nausea,15869418,3
0,21.1,Death,15869499,5
1,21.1,Dysphagia,15869499,6
2,21.1,Pneumonia aspiration,15869499,6
3,21.1,Off label use,15869499,6
4,21.1,Oesophagitis,15869499,6
5,21.1,Product use in unapproved indication,15869499,6
0,21.1,Product use in unapproved indication,15869567,6
1,21.1,Malignant pleural effusion,15869567,6
0,22.0,Vomiting,15869577,1
1,22.0,Lower respiratory tract infection,15869577,1
2,22.0,Vomiting,15869577,1
3,22.0,Nausea,15869577,1
4,22.0,Pain in jaw,15869577,1
5,22.0,Diarrhoea,15869577,1
6,22.0,Nausea,15869577,1
7,22.0,Vomiting,15869577,3
8,22.0,Excessive eye blinking,15869577,1
0,21.1,Hypersensitivity,15869579,5
0,21.1,Deep vein thrombosis,15869580,6
1,21.1,Condition aggravated,15869580,6
2,21.1,Atrial fibrillation,15869580,1
3,21.1,Mucosal inflammation,15869580,6
4,21.1,Malignant neoplasm progression,15869580,6
5,21.1,Hypokalaemia,15869580,6
6,21.1,Cardiac failure,15869580,1
7,21.1,Haemoptysis,15869580,6
8,21.1,Diarrhoea,15869580,6
0,21.1,Cardiac failure,15869582,5
1,21.1,Malignant neoplasm progression,15869582,5
2,21.1,Hepatic function abnormal,15869582,6
0,21.1,Metastases to lung,15869598,2
1,21.1,Lymphadenopathy mediastinal,15869598,2
2,21.1,Cholecystitis,15869598,6
3,21.1,Renal neoplasm,15869598,6
0,21.1,Hepatocellular injury,15869636,1
0,21.1,Overdose,15869647,1
1,21.1,Febrile neutropenia,15869647,5
0,21.1,Rib fracture,15869671,6
0,21.1,Neoplasm progression,15869672,6
0,21.1,Hair disorder,15869680,3
1,21.1,Anxiety,15869680,3
2,21.1,Madarosis,15869680,3
3,21.1,Hair texture abnormal,15869680,3
4,21.1,Alopecia,15869680,3
5,21.1,Hair colour changes,15869680,3
0,21.1,Gait disturbance,15869759,2
1,21.1,Walking aid user,15869759,2
2,21.1,Rehabilitation therapy,15869759,2
3,21.1,Hip surgery,15869759,2
4,21.1,Fall,15869759,4
5,21.1,Off label use,15869759,1
6,21.1,Physiotherapy,15869759,1
7,21.1,Hip fracture,15869759,4
0,22.1,Cerebral haemorrhage,15869842,5
1,22.1,Transient ischaemic attack,15869842,1
2,22.1,Jaw disorder,15869842,6
3,22.1,Blindness transient,15869842,1
0,21.1,Pancreatitis necrotising,15870341,6
1,21.1,Palmar-plantar erythrodysaesthesia syndrome,15870341,6
2,21.1,Hypertriglyceridaemia,15870341,1
0,21.1,Pyrexia,15871074,2
1,21.1,Headache,15871074,2
2,21.1,Oral pain,15871074,2
0,21.1,Pulmonary oedema,15871099,6
1,21.1,Stomatitis,15871099,6
2,21.1,Hypertension,15871099,6
3,21.1,Fatigue,15871099,6
4,21.1,Pain,15871099,6
0,21.1,Neoplasm progression,15871154,6
0,21.1,Neuropathy peripheral,15871217,1
1,21.1,Hypomagnesaemia,15871217,1
2,21.1,Paronychia,15871217,1
0,21.1,Death,15871262,5
0,21.1,Eye disorder,15871966,3
1,21.1,Breast cancer,15871966,3
2,21.1,Diabetes mellitus,15871966,3
3,21.1,Cataract,15871966,3
4,21.1,Condition aggravated,15871966,3
5,21.1,Peroneal nerve palsy,15871966,3
6,21.1,Memory impairment,15871966,6
7,21.1,Blood pressure abnormal,15871966,3
8,21.1,Nasal septum deviation,15871966,3
9,21.1,Gait disturbance,15871966,3
0,21.1,Gastrointestinal disorder,15872239,6
1,21.1,Non-small cell lung cancer metastatic,15872239,6
0,21.1,Unevaluable event,15872292,6
1,21.1,Non-small cell lung cancer metastatic,15872292,6
0,22.0,Acute promyelocytic leukaemia,15874304,1
0,22.0,Wound,15874309,3
0,22.0,Prostate cancer,15875866,3
1,22.0,Prostatic specific antigen increased,15875866,3
2,22.0,Therapeutic response decreased,15875866,3
0,21.1,Diarrhoea,15875871,1
1,21.1,Palmar-plantar erythrodysaesthesia syndrome,15875871,1
2,21.1,Diarrhoea,15875871,1
0,21.1,Polyneuropathy,15875877,1
1,21.1,Fatigue,15875877,1
0,21.1,Diarrhoea,15875886,1
1,21.1,Hypokalaemia,15875886,1
2,21.1,Palmar-plantar erythrodysaesthesia syndrome,15875886,2
3,21.1,Renal tubular necrosis,15875886,2
4,21.1,Acute kidney injury,15875886,2
0,21.1,Euthanasia,15875986,5
1,21.1,Product use in unapproved indication,15875986,6
0,21.1,Decreased appetite,15875991,6
1,21.1,Apparent death,15875991,6
2,21.1,Dysphagia,15875991,2
3,21.1,Weight loss poor,15875991,2
4,21.1,Diarrhoea,15875991,6
5,21.1,Food refusal,15875991,2
6,21.1,Vomiting,15875991,2
7,21.1,Nausea,15875991,6
8,21.1,Feeling of despair,15875991,2
0,21.1,Death,15876058,5
1,21.1,Respiratory failure,15876058,6
0,22.0,Incorrect dose administered,15876648,6
1,22.0,Off label use,15876648,6
2,22.0,Therapy cessation,15876648,6
0,22.0,Prostatic specific antigen increased,15876651,6
0,21.1,Product dose omission,15876661,6
0,21.1,Oxygen saturation decreased,15876710,1
1,21.1,Tremor,15876710,1
2,21.1,Rash,15876710,1
0,21.1,Abdominal pain,15876712,6
1,21.1,Dyspepsia,15876712,6
2,21.1,Haematotoxicity,15876712,6
3,21.1,Vomiting,15876712,6
4,21.1,Disease progression,15876712,6
5,21.1,Duodenal stenosis,15876712,6
6,21.1,Neutropenia,15876712,6
0,21.1,Death,15876732,5
1,21.1,Product use in unapproved indication,15876732,6
0,22.0,Tinnitus,15876776,3
1,22.0,Hypertension,15876776,3
0,21.1,Venoocclusive liver disease,15876835,1
0,22.0,Dyskinesia,15876859,3
1,22.0,White blood cell count decreased,15876859,6
2,22.0,Seizure,15876859,6
3,22.0,Neutrophil count decreased,15876859,6
4,22.0,Pneumonia,15876859,6
5,22.0,Neutrophil count decreased,15876859,1
6,22.0,Seizure,15876859,6
0,22.0,Spinal pain,15876895,1
1,22.0,Mobility decreased,15876895,1
2,22.0,Malaise,15876895,1
3,22.0,Neutropenia,15876895,1
0,21.1,Lung disorder,15876938,3
0,21.1,Bronchospasm,15876960,1
0,21.1,Glaucoma,15876965,6
0,22.0,Cholangitis,15876989,1
1,22.0,Aspartate aminotransferase increased,15876989,6
2,22.0,Gamma-glutamyltransferase increased,15876989,6
3,22.0,Blood alkaline phosphatase increased,15876989,6
4,22.0,Alanine aminotransferase increased,15876989,6
5,22.0,Cholangitis sclerosing,15876989,6
0,22.0,Chondropathy,15876999,6
1,22.0,Neuropathy peripheral,15876999,6
2,22.0,Arthralgia,15876999,6
0,21.1,Diarrhoea,15877019,1
1,21.1,Febrile bone marrow aplasia,15877019,1
0,21.1,Progressive multifocal leukoencephalopathy,15877051,3
0,21.1,Feeling cold,15877054,1
1,21.1,Tremor,15877054,1
2,21.1,Hypertension,15877054,1
0,21.1,Disease progression,15877068,5
0,21.1,Melaena,15877146,1
0,22.0,Oxygen saturation decreased,15877159,1
1,22.0,Tremor,15877159,1
2,22.0,Rash,15877159,1
3,22.0,Overdose,15877159,6
0,21.1,Hyperglycaemia,15877166,1
1,21.1,Ketosis,15877166,1
0,22.0,Alopecia,15877183,2
0,22.0,Psychological trauma,15877222,6
1,22.0,Alopecia,15877222,3
0,21.1,Alopecia,15877225,3
0,22.0,Alopecia,15877250,2
0,21.1,Alopecia,15877254,2
1,21.1,Psychological trauma,15877254,6
0,21.1,Alopecia,15877258,2
1,21.1,Psychological trauma,15877258,6
0,21.1,Alopecia,15877300,3
0,22.0,Alopecia,15877319,3
0,21.1,Psychological trauma,15877322,6
1,21.1,Alopecia,15877322,2
0,21.1,Alopecia,15877404,3
0,22.1,Malignant neoplasm progression,15877442,3
1,22.1,Hepatic function abnormal,15877442,1
2,22.1,Pleural effusion,15877442,1
3,22.1,Febrile neutropenia,15877442,1
4,22.1,Enterocolitis,15877442,3
5,22.1,Pyrexia,15877442,1
6,22.1,Diarrhoea,15877442,1
0,22.0,Renal colic,15877461,1
1,22.0,Enteritis,15877461,1
2,22.0,Intestinal obstruction,15877461,1
0,21.1,Tremor,15877478,1
1,21.1,Rash,15877478,1
2,21.1,Oxygen saturation decreased,15877478,1
0,21.1,Cholangitis infective,15877498,6
1,21.1,Death,15877498,5
0,21.1,Hypercapnia,15877511,5
1,21.1,Liver disorder,15877511,5
2,21.1,Hypoglycaemia,15877511,5
3,21.1,Lung neoplasm malignant,15877511,5
4,21.1,Hyperkalaemia,15877511,5
0,21.1,Peripheral sensorimotor neuropathy,15877538,3
0,21.1,Spinal fracture,15877555,3
1,21.1,Haemoglobin decreased,15877555,1
2,21.1,Fall,15877555,6
3,21.1,Platelet count decreased,15877555,1
0,21.1,Adverse event,15877585,6
1,21.1,Adverse event,15877585,6
2,21.1,Cholelithotomy,15877585,6
3,21.1,Product use in unapproved indication,15877585,6
4,21.1,Biliary tract dilation procedure,15877585,6
0,22.0,Tinnitus,15877633,6
1,22.0,Vertigo,15877633,6
0,21.1,Bile duct cancer,15877653,5
1,21.1,Renal failure,15877653,5
2,21.1,Product use in unapproved indication,15877653,6
0,21.1,Cerebral ischaemia,15877684,1
1,21.1,Urinary tract infection,15877684,3
2,21.1,Haemoglobin decreased,15877684,6
3,21.1,Cerebral infarction,15877684,2
4,21.1,Leukopenia,15877684,1
5,21.1,Red blood cell count decreased,15877684,6
6,21.1,C-reactive protein increased,15877684,6
7,21.1,Cerebral artery embolism,15877684,2
8,21.1,White blood cell count decreased,15877684,6
9,21.1,Pruritus,15877684,1
10,21.1,Anaemia,15877684,1
11,21.1,Haematocrit decreased,15877684,6
12,21.1,Blood sodium decreased,15877684,6
0,21.1,Acute myeloid leukaemia,15877716,6
0,21.1,Febrile neutropenia,15877805,1
0,21.1,Flushing,15877811,1
1,21.1,Polydipsia,15877811,1
2,21.1,Hyponatraemia,15877811,1
0,22.0,Dehydration,15877814,3
1,22.0,Blood creatine increased,15877814,3
0,21.1,Pneumothorax,15877831,1
0,22.1,Abdominal distension,15877837,6
1,22.1,Vomiting,15877837,6
2,22.1,Nausea,15877837,6
3,22.1,Abdominal operation,15877837,6
4,22.1,Constipation,15877837,3
5,22.1,Decreased appetite,15877837,3
0,21.1,Central nervous system lesion,15877900,6
1,21.1,Fatigue,15877900,6
2,21.1,Encephalitis,15877900,6
0,21.1,Sepsis,15877953,1
1,21.1,General physical health deterioration,15877953,1
2,21.1,Autoimmune hepatitis,15877953,1
3,21.1,Renal failure,15877953,1
0,21.1,Pollakiuria,15877991,3
1,21.1,Circumstance or information capable of leading to medication error,15877991,6
2,21.1,Product dose omission,15877991,6
3,21.1,Product availability issue,15877991,6
0,21.1,Nasopharyngitis,15878013,2
1,21.1,Pain,15878013,1
0,22.0,Small intestinal obstruction,15878021,1
0,21.1,Female genital tract fistula,15878056,3
0,21.1,Abdominal pain,15878064,6
1,21.1,Rash,15878064,6
2,21.1,Delirium,15878064,6
3,21.1,Radiation hepatitis,15878064,6
4,21.1,Hypoalbuminaemia,15878064,6
5,21.1,Nausea,15878064,6
6,21.1,Gastrointestinal ulcer,15878064,6
7,21.1,Vomiting,15878064,6
8,21.1,Aspartate aminotransferase increased,15878064,6
9,21.1,Hyperbilirubinaemia,15878064,6
10,21.1,Neutrophil count decreased,15878064,6
11,21.1,Pulmonary embolism,15878064,6
12,21.1,Pyrexia,15878064,6
13,21.1,Acute kidney injury,15878064,6
14,21.1,Intestinal obstruction,15878064,6
15,21.1,Dementia,15878064,6
16,21.1,Platelet count decreased,15878064,6
17,21.1,Fatigue,15878064,6
18,21.1,Liver abscess,15878064,6
19,21.1,Gastritis,15878064,6
20,21.1,International normalised ratio increased,15878064,6
21,21.1,Alanine aminotransferase increased,15878064,6
22,21.1,Sepsis,15878064,6
0,21.1,Haemorrhage,15878067,1
1,21.1,Fatigue,15878067,1
2,21.1,Anaemia,15878067,1
3,21.1,Influenza like illness,15878067,1
0,22.0,Pyrexia,15878068,1
1,22.0,Anaemia,15878068,1
2,22.0,Disease progression,15878068,
3,22.0,Drug interaction,15878068,6
4,22.0,Off label use,15878068,6
5,22.0,Haemorrhage,15878068,1
6,22.0,Influenza like illness,15878068,1
0,21.1,Proteinuria,15878072,1
1,21.1,Influenza like illness,15878072,1
2,21.1,Hypotension,15878072,1
3,21.1,Off label use,15878072,6
4,21.1,Pyrexia,15878072,1
0,21.1,Pain,15878076,1
1,21.1,Tremor,15878076,1
0,22.1,Restrictive pulmonary disease,15878079,5
1,22.1,Ascites,15878079,3
2,22.1,Pleural effusion,15878079,5
3,22.1,Respiratory failure,15878079,5
4,22.1,Metastases to pleura,15878079,5
5,22.1,Anaemia,15878079,5
6,22.1,Neutropenia,15878079,2
7,22.1,Concomitant disease aggravated,15878079,5
8,22.1,C-reactive protein increased,15878079,6
9,22.1,Hypokalaemia,15878079,1
10,22.1,Pneumothorax,15878079,5
11,22.1,Leukopenia,15878079,5
12,22.1,Pneumonia,15878079,5
0,21.1,Abdominal pain,15878093,2
1,21.1,Dyspnoea,15878093,2
0,21.1,Hyperkeratosis,15878098,6
1,21.1,Diarrhoea,15878098,6
2,21.1,Underdose,15878098,6
0,21.1,Diarrhoea,15878136,6
0,21.1,Diarrhoea,15878138,6
0,21.1,Vision blurred,15878196,6
1,21.1,Lethargy,15878196,6
0,21.1,Death,15878197,
0,21.1,Malaise,15878199,6
0,22.0,Hair colour changes,15878250,6
1,22.0,Hair disorder,15878250,6
2,22.0,Alopecia,15878250,3
3,22.0,Hair texture abnormal,15878250,6
4,22.0,Madarosis,15878250,6
0,22.0,Somnolence,15878265,1
1,22.0,Neoplasm progression,15878265,6
2,22.0,Asthenia,15878265,1
0,21.1,Alopecia,15878275,3
1,21.1,Hair disorder,15878275,3
2,21.1,Hair colour changes,15878275,3
3,21.1,Hair texture abnormal,15878275,3
0,22.0,Hair disorder,15878297,3
1,22.0,Hair texture abnormal,15878297,3
2,22.0,Hair colour changes,15878297,3
3,22.0,Alopecia,15878297,3
4,22.0,Madarosis,15878297,3
0,22.0,Arthralgia,15878320,1
1,22.0,Chondropathy,15878320,6
2,22.0,Neuropathy peripheral,15878320,3
0,22.0,Hair texture abnormal,15878333,3
1,22.0,Hair colour changes,15878333,3
2,22.0,Madarosis,15878333,3
3,22.0,Hair disorder,15878333,3
4,22.0,Alopecia,15878333,3
0,22.0,Madarosis,15878335,3
1,22.0,Hair disorder,15878335,3
2,22.0,Anxiety,15878335,3
3,22.0,Alopecia,15878335,3
4,22.0,Hair colour changes,15878335,3
5,22.0,Hair texture abnormal,15878335,3
6,22.0,Depression,15878335,6
0,22.0,Hair texture abnormal,15878343,3
1,22.0,Hair disorder,15878343,3
2,22.0,Alopecia,15878343,3
3,22.0,Hair colour changes,15878343,3
4,22.0,Madarosis,15878343,3
0,21.1,Chemical peritonitis,15878404,6
1,21.1,Renal impairment,15878404,6
2,21.1,White blood cell count decreased,15878404,6
3,21.1,Neurotoxicity,15878404,6
4,21.1,Platelet count decreased,15878404,6
5,21.1,Alopecia,15878404,6
6,21.1,Gastrointestinal disorder,15878404,6
0,21.1,Arrhythmia,15878406,5
1,21.1,Pulmonary embolism,15878406,5
2,21.1,Myocardial infarction,15878406,5
0,21.1,Pleural effusion,15878420,1
1,21.1,Pulmonary oedema,15878420,6
0,21.1,Pyrexia,15878452,1
1,21.1,Joint injury,15878452,1
2,21.1,Cystitis,15878452,1
3,21.1,Head injury,15878452,1
4,21.1,Fall,15878452,1
5,21.1,Lower respiratory tract infection,15878452,1
0,22.0,Vertigo,15878478,1
1,22.0,Fatigue,15878478,1
0,21.1,Fatigue,15878504,3
1,21.1,Hot flush,15878504,3
2,21.1,Drug ineffective,15878504,3
3,21.1,Fall,15878504,6
4,21.1,Asthenia,15878504,3
0,22.0,Inappropriate schedule of product administration,15878513,6
1,22.0,Transfusion,15878513,6
2,22.0,Adverse event,15878513,6
3,22.0,Adverse event,15878513,6
4,22.0,Product use in unapproved indication,15878513,6
0,22.1,Platelet count decreased,15878530,6
0,21.1,Pericardial effusion,15878542,2
1,21.1,Product use in unapproved indication,15878542,6
2,21.1,Malignant neoplasm of thymus,15878542,2
0,21.1,Hospitalisation,15878551,6
0,21.1,Myocardial infarction,15878553,5
1,21.1,Anaemia,15878553,3
2,21.1,Pleural effusion,15878553,6
3,21.1,Leukopenia,15878553,1
4,21.1,Neutropenia,15878553,1
5,21.1,Pyrexia,15878553,1
6,21.1,Infection,15878553,3
7,21.1,Polyneuropathy,15878553,3
0,21.1,Death,15878554,5
0,22.0,Pain in extremity,15878583,2
1,22.0,Peripheral swelling,15878583,2
2,22.0,Malignant pleural effusion,15878583,6
3,22.0,Gastroenteritis,15878583,1
4,22.0,C-reactive protein increased,15878583,6
5,22.0,Urine ketone body present,15878583,6
6,22.0,Mobility decreased,15878583,2
7,22.0,Blood sodium decreased,15878583,6
8,22.0,White blood cell count decreased,15878583,6
9,22.0,Haemoglobin decreased,15878583,6
10,22.0,Blood potassium decreased,15878583,6
11,22.0,Platelet count decreased,15878583,6
12,22.0,Dyspnoea,15878583,1
0,21.1,Death,15878597,5
0,21.1,Malaise,15878608,6
0,22.0,Pleural effusion,15878615,6
1,22.0,Hypertension,15878615,6
0,22.1,Fatigue,15878639,6
1,22.1,Poor quality sleep,15878639,6
2,22.1,Malaise,15878639,6
3,22.1,Neuropathy peripheral,15878639,6
4,22.1,Weight decreased,15878639,6
5,22.1,Insomnia,15878639,6
6,22.1,Blood pressure increased,15878639,6
7,22.1,Panic reaction,15878639,6
8,22.1,Gastric disorder,15878639,6
9,22.1,Memory impairment,15878639,6
10,22.1,Asthenia,15878639,6
0,22.0,Diarrhoea,15878642,3
1,22.0,Nausea,15878642,3
2,22.0,Headache,15878642,3
3,22.0,Fatigue,15878642,6
0,22.0,Movement disorder,15878644,6
0,22.1,Spinal fracture,15878653,6
1,22.1,Alopecia,15878653,6
2,22.1,Intervertebral disc protrusion,15878653,6
3,22.1,Pain,15878653,6
4,22.1,White blood cell count decreased,15878653,6
5,22.1,Insomnia,15878653,6
6,22.1,Product use in unapproved indication,15878653,6
7,22.1,Stress,15878653,6
8,22.1,Fall,15878653,6
9,22.1,Road traffic accident,15878653,6
10,22.1,Off label use,15878653,6
11,22.1,Injury,15878653,6
12,22.1,Tendonitis,15878653,6
13,22.1,Neoplasm progression,15878653,6
0,21.1,Nausea,15878661,6
1,21.1,Vomiting,15878661,6
2,21.1,Throat tightness,15878661,6
3,21.1,Dysphagia,15878661,6
0,22.1,White blood cell count decreased,15878663,2
1,22.1,Decreased appetite,15878663,2
2,22.1,Prescribed overdose,15878663,6
3,22.1,Ill-defined disorder,15878663,1
4,22.1,Product dose omission,15878663,6
5,22.1,Neoplasm progression,15878663,6
6,22.1,Platelet count decreased,15878663,6
7,22.1,Back disorder,15878663,6
0,22.0,White blood cell count decreased,15878677,6
1,22.0,Bronchitis,15878677,6
0,22.0,Madarosis,15878699,3
1,22.0,Alopecia,15878699,3
